Tous les communiqués | WebDisclosure

Switch to English

10443	Sociétés
219236	Mots-clés
148697	Articles
115970	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:07, il y a 1 année 4 mois

Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
The Vanguard Group, Inc. disclosed a 5.50% ownership in Direct Line Insurance Group plc. They made purchases of 10 10/11p ordinary shares at 2.56 GBP per unit

Vanguard Group Ownership Disclosure Financial Disclosure Stock Purchases Direct Line Insurance
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:06, il y a 1 année 4 mois

Form 8.3 - The Vanguard Group, Inc.: Aviva plc
The Vanguard Group, Inc. discloses a 5.04% ownership stake in Aviva plc. Additional disclosure made for Direct Line Insurance Group plc

The Vanguard Group, Inc. Disclosure Ownership Stake Direct Line Insurance Group Plc Aviva Plc
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:05, il y a 1 année 4 mois

Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
The Vanguard Group, Inc. discloses 3.99% stake in Hargreaves Lansdown plc. Form 8.3 filing on 09-Jan-2025

Form 8.3 Financial Filing Vanguard Group Stake Disclosure Hargreaves Lansdown Plc
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:04, il y a 1 année 4 mois

Form 8.3 - The Vanguard Group, Inc.: Britvic plc
The Vanguard Group, Inc. discloses holding 5.52% stake in Britvic plc as of 08 Jan 2025 per Form 8.3 filing under Rule 8.3 of the Takeover Code

The Vanguard Group, Inc. Form 8.3 Britvic Plc Rule 8.3 Takeover Code
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:03, il y a 1 année 4 mois

Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
The Vanguard Group, Inc. discloses a 4.96% stake in Smith (DS) plc on 8 Jan 2025. Also involved in disclosures related to International Paper Company

The Vanguard Group, Inc. Disclosure Smith (DS) Plc Stake International Paper Company
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:00, il y a 1 année 4 mois

Laxxon Medical Announces Appointment of Two New Members to Board of Directors
Laxxon Medical appoints Christof Bircher and Nneka Ukpai as new independent directors, bringing extensive experience to further the company's strategy and long-term shareholder value

Board Of Directors Pharmaceutical Industry Laxxon Medical Christof Bircher Nneka Ukpai
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 15:00, il y a 1 année 4 mois

BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco
BioLizard appoints Arjan van Manen as Commercial Director, introduces AI-native application Bio|Verse Navigator. Meet the team at JPM Week in San Francisco for innovative solutions in life sciences

BioLizard Commercial Director Arjan Van Manen JPM Week AI-native Application
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 14:42, il y a 1 année 4 mois

Form 8.3 - Opening Position Disclosure - Team Internet Group PLC
Chelverton Asset Management discloses a 2.36% interest in Team Internet Group PLC. Form 8.3 submitted on 09-Jan-2025

Team Internet Group Plc Form 8.3 Disclosure Chelverton Asset Management 2.36% Interest 09-Jan-2025
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 14:34, il y a 1 année 4 mois

Edison issues report on BlackRock Greater Europe Investment Trust (BRGE)
Edison issues report on BlackRock Greater Europe Investment Trust (BRGE) highlighting performance and positive prospects amid economic challenges

Europe Performance Edison BlackRock Investment Trust
COMMUNIQUÉ DE PRESSE

publié le 09/01/2025 à 14:30, il y a 1 année 4 mois

UniDoc - Company Recognizes Initial Revenue on Delivery of AI-Equipped H3 Health Cubes
UniDoc Health Corp. delivers AI-assisted H3 Health Cubes to three commercial customers, including Aiutamoli a Vivere Foundation, Municipality of Aliano, and Okhmatdyt Children's Hospital, for immediate deployment

AI Technology Healthcare Accessibility UniDoc Health Corp. H3 Health Cubes EHealth Sector

Les Echos

Publié le 22/05/2026 à 19:35, il y a 20 heures 32 minutes

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Publié le 22/05/2026 à 18:05, il y a 22 heures 1 minute

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Publié le 22/05/2026 à 18:05, il y a 22 heures 1 minute

Disclosure of transactions in own shares from May 18 to May 22, 2026
Publié le 22/05/2026 à 12:52, il y a 1 jour 3 heures

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Publié le 22/05/2026 à 12:52, il y a 1 jour 3 heures

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 23/05/2026 à 03:15, il y a 12 heures 52 minutes

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Publié le 23/05/2026 à 03:00, il y a 13 heures 7 minutes

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Publié le 23/05/2026 à 02:25, il y a 13 heures 42 minutes

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Publié le 23/05/2026 à 02:25, il y a 13 heures 42 minutes

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Publié le 23/05/2026 à 01:00, il y a 15 heures 7 minutes

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

Voir tout ACCESSWIRE

EQS Group

Publié le 23/05/2026 à 15:57, il y a 10 minutes

EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Publié le 22/05/2026 à 22:05, il y a 18 heures 2 minutes

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Publié le 22/05/2026 à 22:05, il y a 18 heures 2 minutes

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Publié le 22/05/2026 à 19:51, il y a 20 heures 15 minutes

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Publié le 22/05/2026 à 18:33, il y a 21 heures 34 minutes

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring